• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA:炎症性疾病中炎性小体的主要调节因子

Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases.

作者信息

Wang Wei, Yang Ni, Yang Yu-Hang, Wen Ri, Liu Chun-Feng, Zhang Tie-Ning

机构信息

Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.

出版信息

J Inflamm Res. 2021 Sep 30;14:5023-5050. doi: 10.2147/JIR.S332840. eCollection 2021.

DOI:10.2147/JIR.S332840
PMID:34616171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8490125/
Abstract

Emerging data indicates that non-coding RNAs (ncRNAs) represent more than just "junk sequences" of the genome and have been found to be involved in multiple diseases by regulating various biological process, including the activation of inflammasomes. As an important aspect of innate immunity, inflammasomes are large immune multiprotein complexes that tightly regulate the production of pro-inflammatory cytokines and mediate pyroptosis; the activation of the inflammasomes is a vital biological process in inflammatory diseases. Recent studies have emphasized the function of ncRNAs in the fine control of inflammasomes activation either by directly targeting components of the inflammasomes or by controlling the activity of various factors that control the activation of inflammasomes; consequently, ncRNAs may represent potential therapeutic targets for inflammatory diseases. Understanding the precise role of ncRNAs in controlling the activation of inflammasomes will help us to design targeted therapies for multiple inflammatory diseases. In this review, we summarize the regulatory role and therapeutic potential of ncRNAs in the activation of inflammasomes by focusing on a range of inflammatory diseases, including microbial infection, sterile inflammatory diseases, and fibrosis-related diseases. Our goal is to provide new ideas and perspectives for future research.

摘要

新出现的数据表明,非编码RNA(ncRNAs)并非仅仅是基因组的“垃圾序列”,而且已发现其通过调控包括炎性小体激活在内的各种生物学过程而参与多种疾病。作为固有免疫的一个重要方面,炎性小体是大型免疫多蛋白复合物,可严格调控促炎细胞因子的产生并介导细胞焦亡;炎性小体的激活是炎症性疾病中的一个重要生物学过程。最近的研究强调了ncRNAs在炎性小体激活的精细调控中的作用,其方式要么是直接靶向炎性小体的组分,要么是控制各种调控炎性小体激活的因子的活性;因此,ncRNAs可能代表炎症性疾病的潜在治疗靶点。了解ncRNAs在控制炎性小体激活中的精确作用将有助于我们设计针对多种炎症性疾病的靶向治疗方法。在本综述中,我们通过聚焦一系列炎症性疾病,包括微生物感染、无菌性炎症性疾病和纤维化相关疾病,总结了ncRNAs在炎性小体激活中的调控作用和治疗潜力。我们的目标是为未来的研究提供新的思路和观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/a31963ca3d1b/JIR-14-5023-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/7c97443c0cd6/JIR-14-5023-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/aec5aee37acb/JIR-14-5023-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/a31963ca3d1b/JIR-14-5023-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/7c97443c0cd6/JIR-14-5023-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/aec5aee37acb/JIR-14-5023-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/8490125/a31963ca3d1b/JIR-14-5023-g0003.jpg

相似文献

1
Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases.非编码RNA:炎症性疾病中炎性小体的主要调节因子
J Inflamm Res. 2021 Sep 30;14:5023-5050. doi: 10.2147/JIR.S332840. eCollection 2021.
2
Interaction among inflammasome, autophagy and non-coding RNAs: new horizons for drug.炎性小体、自噬与非编码RNA之间的相互作用:药物研发的新视野
Precis Clin Med. 2019 Sep;2(3):166-182. doi: 10.1093/pcmedi/pbz019. Epub 2019 Oct 1.
3
Regulation of pyroptosis in cardiovascular pathologies: Role of noncoding RNAs.心血管疾病中细胞焦亡的调控:非编码RNA的作用
Mol Ther Nucleic Acids. 2021 May 29;25:220-236. doi: 10.1016/j.omtn.2021.05.016. eCollection 2021 Sep 3.
4
Inactivation of Inflammasomes by Pathogens Regulates Inflammation.病原体对炎性小体的失活作用调控炎症反应。
Biochemistry (Mosc). 2016 Nov;81(11):1326-1339. doi: 10.1134/S0006297916110109.
5
Role of inflammasomes in inflammatory autoimmune rheumatic diseases.炎性小体在炎症性自身免疫性风湿病中的作用。
Korean J Physiol Pharmacol. 2018 Jan;22(1):1-15. doi: 10.4196/kjpp.2018.22.1.1. Epub 2017 Dec 22.
6
NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.NLRP3 炎性小体:肥胖相关低度慢性炎症与结直肠癌发展之间的可能联系。
Front Immunol. 2018 Dec 11;9:2918. doi: 10.3389/fimmu.2018.02918. eCollection 2018.
7
Non-coding RNA-mediated epigenetic regulation of liver fibrosis.非编码 RNA 介导的肝纤维化表观遗传调控。
Metabolism. 2015 Nov;64(11):1386-94. doi: 10.1016/j.metabol.2015.08.004. Epub 2015 Aug 14.
8
Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases.牙龈卟啉单胞菌对牙周炎及相关系统性疾病中炎症小体活性的调节作用。
J Oral Microbiol. 2016 Feb 4;8:30385. doi: 10.3402/jom.v8.30385. eCollection 2016.
9
The role of inflammasomes in kidney disease.炎症小体在肾脏疾病中的作用。
Nat Rev Nephrol. 2019 Aug;15(8):501-520. doi: 10.1038/s41581-019-0158-z.
10
Inflammasome as a New Therapeutic Target for Diabetic Complications.炎症小体作为糖尿病并发症的新治疗靶点。
Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):56-62. doi: 10.2174/1872214810666160219163314.

引用本文的文献

1
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.非编码RNA:癌症和炎症性疾病中新兴的生物标志物及治疗靶点
Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025.
2
LncRNA BRE-AS1 regulates the JAK2/STAT3-mediated inflammatory activation via the miR-30b-5p/SOC3 axis in THP-1 cells.长链非编码 RNA BRE-AS1 通过 miR-30b-5p/SOC3 轴调控 JAK2/STAT3 介导的 THP-1 细胞炎症激活。
Sci Rep. 2024 Oct 28;14(1):25726. doi: 10.1038/s41598-024-77265-1.
3
Non-coding RNAs as a Critical Player in the Regulation of Inflammasome in Inflammatory Bowel Diseases; Emphasize on lncRNAs.

本文引用的文献

1
LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22/NLRP3 axis in hyperuricaemia.长链非编码 RNA-HOTAIR 通过调节 miR-22/NLRP3 轴促进高尿酸血症内皮细胞焦亡。
J Cell Mol Med. 2021 Sep;25(17):8504-8521. doi: 10.1111/jcmm.16812. Epub 2021 Jul 22.
2
Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation.末端尿嘧啶转移酶 7 通过控制 Regnase-1 mRNA 的尿嘧啶化和降解来调节 TLR4 触发的炎症。
Nat Commun. 2021 Jun 29;12(1):3878. doi: 10.1038/s41467-021-24177-7.
3
Overexpression of lncRNA TUG1 Alleviates NLRP3 Inflammasome-Mediated Cardiomyocyte Pyroptosis Through Targeting the miR-186-5p/XIAP Axis in Coronary Microembolization-Induced Myocardial Damage.
非编码RNA作为炎症性肠病中炎性小体调节的关键参与者;重点关注长链非编码RNA。
Cell Biochem Biophys. 2025 Jun;83(2):1359-1374. doi: 10.1007/s12013-024-01585-2. Epub 2024 Oct 19.
4
Emerging Role of Long Noncoding RNAs in Regulating Inflammasome-Mediated Neurodegeneration in Parkinson's Disease.长链非编码 RNA 在调控帕金森病中炎症小体介导的神经退行性变中的新兴作用
Mol Neurobiol. 2024 Jul;61(7):4619-4632. doi: 10.1007/s12035-023-03809-7. Epub 2023 Dec 18.
5
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.长链非编码 RNA ANRIL、THRIL 和 NEAT1 作为 SARS-CoV-2 感染和疾病严重程度的潜在循环生物标志物。
Virus Res. 2023 Oct 15;336:199214. doi: 10.1016/j.virusres.2023.199214. Epub 2023 Sep 11.
6
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression.复发缓解型多发性硬化症患者中Lnc-EGFR、SNHG1和LincRNA-Cox2表达谱的改变:对疾病活动和进展的影响
Diagnostics (Basel). 2023 Apr 17;13(8):1448. doi: 10.3390/diagnostics13081448.
7
An overview of natural products that modulate the expression of non-coding RNAs involved in oxidative stress and inflammation-associated disorders.调节参与氧化应激和炎症相关疾病的非编码RNA表达的天然产物概述。
Front Pharmacol. 2023 Apr 24;14:1144836. doi: 10.3389/fphar.2023.1144836. eCollection 2023.
8
AIM2 and Psoriasis.AIM2 与银屑病。
Front Immunol. 2023 Jan 18;14:1085448. doi: 10.3389/fimmu.2023.1085448. eCollection 2023.
9
The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease.MALAT-1、NEAT-1、THRIL 和 miR-155-5p 在 COVID-19 疾病的急性期到亚急性期的表达模式。
Braz J Infect Dis. 2022 May-Jun;26(3):102354. doi: 10.1016/j.bjid.2022.102354. Epub 2022 Apr 25.
长链非编码 RNA TUG1 的过表达通过靶向 miR-186-5p/XIAP 轴缓解冠状动脉微栓塞诱导心肌损伤中的 NLRP3 炎性小体介导的心肌细胞细胞焦亡。
Front Immunol. 2021 Jun 7;12:637598. doi: 10.3389/fimmu.2021.637598. eCollection 2021.
4
The role of HMGB1 on TDI-induced NLPR3 inflammasome activation via ROS/NF-κB pathway in HBE cells.HMGB1 在 TDI 诱导的 HBE 细胞 NLPR3 炎性体激活中通过 ROS/NF-κB 通路的作用。
Int Immunopharmacol. 2021 Sep;98:107859. doi: 10.1016/j.intimp.2021.107859. Epub 2021 Jun 18.
5
Overexpression of miR-224-5p alleviates allergic rhinitis in mice via the TLR4/MyD88/NF-κB pathway.miR-224-5p 的过表达通过 TLR4/MyD88/NF-κB 通路缓解小鼠变应性鼻炎。
Exp Anim. 2021 Nov 10;70(4):440-449. doi: 10.1538/expanim.20-0195. Epub 2021 Jun 7.
6
Circular RNA circHIPK3 Activates Macrophage NLRP3 Inflammasome and TLR4 Pathway in Gouty Arthritis via Sponging miR-561 and miR-192.环状 RNA circHIPK3 通过海绵吸附 miR-561 和 miR-192 激活痛风性关节炎中的巨噬细胞 NLRP3 炎性体和 TLR4 通路。
Inflammation. 2021 Oct;44(5):2065-2077. doi: 10.1007/s10753-021-01483-2. Epub 2021 Jun 4.
7
CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.环状Helz通过在小鼠缺血性心脏中吸附miR-133a-3p激活NLRP3炎性小体,从而促进心肌损伤。
J Mol Cell Cardiol. 2021 Sep;158:128-139. doi: 10.1016/j.yjmcc.2021.05.010. Epub 2021 May 25.
8
Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models.靶向新型 hsa_circ_0000520/miR-556-5p/NLRP3 通路介导的细胞焦亡和炎症可减轻卵清蛋白 (OVA) 诱导的小鼠变应性鼻炎 (AR)。
Inflamm Res. 2021 Jun;70(6):719-729. doi: 10.1007/s00011-021-01472-z. Epub 2021 May 24.
9
Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?多基因自身炎症性疾病中的白细胞介素-1阻断:我们现在处于什么阶段?
Front Pharmacol. 2021 Jan 26;11:619273. doi: 10.3389/fphar.2020.619273. eCollection 2020.
10
AIM2 inflammasome activation may mediate high mobility group box 1 release in murine allergic rhinitis.AIM2 炎性小体的激活可能介导了高迁移率族蛋白 B1 在变应性鼻炎中的释放。
Braz J Otorhinolaryngol. 2022 Nov-Dec;88(6):925-931. doi: 10.1016/j.bjorl.2020.12.014. Epub 2021 Feb 15.